Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyBiologicalProcessembryonic cranial skeleton morphogenesis

IFT140 SETD2 GRHL2 NIPBL

6.44e-0652484GO:0048701
GeneOntologyBiologicalProcesscranial skeletal system development

IFT140 SETD2 GRHL2 NIPBL

4.34e-0584484GO:1904888
GeneOntologyCellularComponenteukaryotic translation initiation factor 3 complex, eIF3m

EIF3C EIF3CL

1.76e-049472GO:0071541
GeneOntologyCellularComponenteukaryotic translation initiation factor 3 complex

EIF3C EIF3CL

5.82e-0416472GO:0005852
GeneOntologyCellularComponenteukaryotic 48S preinitiation complex

EIF3C EIF3CL

7.40e-0418472GO:0033290
GeneOntologyCellularComponenteukaryotic 43S preinitiation complex

EIF3C EIF3CL

8.26e-0419472GO:0016282
GeneOntologyCellularComponenttranslation preinitiation complex

EIF3C EIF3CL

9.16e-0420472GO:0070993
MousePhenobelly spot

ETS1 COP1 EIF3C EIF3CL

6.58e-0641424MP:0000373
MousePhenowhite spotting

ETS1 COP1 EIF3C EIF3CL

1.47e-0550424MP:0002938
MousePhenoopen neural tube

TRPM6 IFT140 SETD2 TRAF4 GRHL2 DNMT1

5.39e-05226426MP:0000929
MousePhenoabnormal thoracic cage morphology

KY IFT140 TRAF4 LMNB1 SGPL1 GRHL2 RUNDC1 NIPBL

5.97e-05463428MP:0004624
MousePhenoabnormal vertebral column morphology

TRPM6 KY TPTE IFT140 TRAF4 LMNB1 SGPL1 CNTNAP1 NEB RUNDC1

8.57e-057874210MP:0004703
MousePhenoabnormal hallux morphology

EIF3C EIF3CL

8.76e-055422MP:0009049
MousePhenoabnormal neural tube closure

TRPM6 IFT140 SETD2 TRAF4 UGGT1 GRHL2 DNMT1

1.19e-04378427MP:0003720
MousePhenospina bifida

TRPM6 IFT140 TRAF4 GRHL2

1.31e-0487424MP:0003054
MousePhenoabnormal axial skeleton morphology

TRPM6 KY TPTE IFT140 TRAF4 LMNB1 SGPL1 CNTNAP1 NEB LYN GRHL2 RUNDC1 NIPBL

2.30e-0414584213MP:0002114
MousePhenoabnormal neural tube morphology

TRPM6 IFT140 SETD2 TRAF4 UGGT1 ETS1 GRHL2 DNMT1

3.22e-04591428MP:0002151
MousePhenoabnormal spine curvature

KY TPTE TRAF4 LMNB1 CNTNAP1 NEB

3.48e-04318426MP:0004174
MousePhenoabnormal head shape

LMNB1 UGGT1 GRHL2 NIPBL

3.82e-04115424MP:0011495
MousePhenohead spot

EIF3C EIF3CL

3.91e-0410422MP:0002939
DomainTransform_prot_C-ets

ETS1 ETS2

6.74e-062492IPR016311
DomainEIF3C_N_dom

EIF3C EIF3CL

6.74e-062492IPR008905
DomaineIF-3c_N

EIF3C EIF3CL

6.74e-062492PF05470
DomainEIF3C

EIF3C EIF3CL

6.74e-062492IPR027516
DomainWHTH_DNA-bd_dom

ETS1 ETS2 EIF3C ASCC3 RFX1 EIF3CL

3.90e-05242496IPR011991
Domain-

ETS1 ETS2 EIF3C RFX1 EIF3CL

2.60e-042184951.10.10.10
DomainPNT

ETS1 ETS2

3.65e-0411492PS51433
DomainPointed_dom

ETS1 ETS2

3.65e-0411492IPR003118
DomainSAM_PNT

ETS1 ETS2

3.65e-0411492PF02198
DomainSAM_PNT

ETS1 ETS2

3.65e-0411492SM00251
DomainPINT

EIF3C EIF3CL

7.90e-0416492SM00088
DomainPCI_dom

EIF3C EIF3CL

8.94e-0417492IPR000717
DomainPCI

EIF3C EIF3CL

8.94e-0417492PF01399
DomainFibrinogen_C

CNTNAP1 FGL2

2.27e-0327492PF00147
DomainETS_DOMAIN_1

ETS1 ETS2

2.44e-0328492PS00345
DomainETS_DOMAIN_2

ETS1 ETS2

2.44e-0328492PS00346
DomainETS

ETS1 ETS2

2.44e-0328492SM00413
DomainEts_dom

ETS1 ETS2

2.44e-0328492IPR000418
DomainETS_DOMAIN_3

ETS1 ETS2

2.44e-0328492PS50061
DomainEts

ETS1 ETS2

2.44e-0328492PF00178
DomainFBG

CNTNAP1 FGL2

2.62e-0329492SM00186
Domain-

CNTNAP1 FGL2

2.80e-03304923.90.215.10
DomainFibrinogen_a/b/g_C_1

CNTNAP1 FGL2

2.80e-0330492IPR014716
DomainFIBRINOGEN_C_1

CNTNAP1 FGL2

3.18e-0332492PS00514
DomainFibrinogen_a/b/g_C_dom

CNTNAP1 FGL2

3.18e-0332492IPR002181
DomainFIBRINOGEN_C_2

CNTNAP1 FGL2

3.18e-0332492PS51406
DomainSH3_1

NEB LYN YES1

9.11e-03164493PF00018
PathwayPID_GLYPICAN_1PATHWAY

PLA2G2A LYN YES1

5.91e-0527403M33
Pubmed

ATG5 is required for B cell polarization and presentation of particulate antigens.

S100A8 FAM120A LMNB1 SGPL1 EIF3C ASCC3 LYN DNMT1 EIF3CL

5.22e-0770149930196744
Pubmed

Transcriptional regulation of telomerase activity: roles of the the Ets transcription factor family.

ETS1 ETS2

1.94e-06249217986575
Pubmed

An intricate arrangement of binding sites for the Ets family of transcription factors regulates activity of the alpha 4 integrin gene promoter.

ETS1 ETS2

1.94e-0624928195215
Pubmed

The ets sequence from the transforming gene of avian erythroblastosis virus, E26, has unique domains on human chromosomes 11 and 21: both loci are transcriptionally active.

ETS1 ETS2

1.94e-0624922997781
Pubmed

Differential expression of ets-1 and ets-2 proto-oncogenes during murine embryogenesis.

ETS1 ETS2

1.94e-0624928183549
Pubmed

Transcription factor Ets1, but not the closely related factor Ets2, inhibits antibody-secreting cell differentiation.

ETS1 ETS2

1.94e-06249224277931
Pubmed

Hepatitis B virus-induced hFGL2 transcription is dependent on c-Ets-2 and MAPK signal pathway.

ETS2 FGL2

1.94e-06249218801734
Pubmed

S1P lyase in thymic perivascular spaces promotes egress of mature thymocytes via up-regulation of S1P receptor 1.

SGPL1 S1PR1

1.94e-06249224343820
Pubmed

The Ets family of proteins: weak modulators of gene expression in quest for transcriptional partners.

ETS1 ETS2

1.94e-0624928519813
Pubmed

ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm.

ETS1 ETS2

1.94e-06249218958307
Pubmed

Characterization and localization of the products of the human homologs of the v-ets oncogene.

ETS1 ETS2

1.94e-0624923285299
Pubmed

Ets-1 and Ets-2 protooncogene expression in theca cells of the adult mouse ovary.

ETS1 ETS2

1.94e-0624921511734
Pubmed

EIF3C Promotes Lung Cancer Tumorigenesis by Regulating the APP/HSPA1A/LMNB1 Axis.

EIF3C EIF3CL

1.94e-06249236157221
Pubmed

Mammalian ets-1 and ets-2 genes encode highly conserved proteins.

ETS1 ETS2

1.94e-0624922847145
Pubmed

The avian and mammalian ets genes: molecular characterization, chromosome mapping, and implication in human leukemia.

ETS1 ETS2

1.94e-0624923019221
Pubmed

c-ETS transcription factors play an essential role in the licensing of human MCM4 origin of replication.

ETS1 ETS2

1.94e-06249226365772
Pubmed

In vivo modulation of ETS genes induced by electromagnetic fields.

ETS1 ETS2

1.94e-06249211887334
Pubmed

Phosphorylation of ETS1 by Src family kinases prevents its recognition by the COP1 tumor suppressor.

ETS1 ETS2 COP1

2.11e-061849325117710
Pubmed

Precise developmental regulation of Ets family transcription factors during specification and commitment to the T cell lineage.

ETS1 ETS2

5.83e-06349210375504
Pubmed

Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoter.

ETS1 ETS2

5.83e-06349211279115
Pubmed

Differential mitotic activation of endogenous c-Src, c-Yes, and Lyn in HeLa cells.

LYN YES1

5.83e-06349217692281
Pubmed

Yes and Lyn play a role in nuclear translocation of the epidermal growth factor receptor.

LYN YES1

5.83e-06349222430206
Pubmed

Genetic Interaction between Lyn, Ets1, and Btk in the Control of Antibody Levels.

ETS1 LYN

5.83e-06349226209625
Pubmed

Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.

SGPL1 S1PR1

5.83e-06349226493335
Pubmed

Ets-1 and Ets-2 regulate the expression of microRNA-126 in endothelial cells.

ETS1 ETS2

5.83e-06349220671229
Pubmed

Conserved chromosomal positions of dual domains of the ets protooncogene in cats, mice, and humans.

ETS1 ETS2

5.83e-0634923513188
Pubmed

Sp100 interacts with ETS-1 and stimulates its transcriptional activity.

ETS1 ETS2

5.83e-06349211909962
Pubmed

Analysis of gene networks in white adipose tissue development reveals a role for ETS2 in adipogenesis.

ETS1 ETS2

5.83e-06349221989915
Pubmed

Inhibition of basal activity of c-jun-NH2-terminal kinase (JNK) represses the expression of presenilin-1 by a p53-dependent mechanism.

ETS1 ETS2

5.83e-06349218374905
Pubmed

An inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 gene.

ETS1 ETS2

5.83e-0634921409581
Pubmed

Sphingosine-1-phosphate lyase deficiency produces a pro-inflammatory response while impairing neutrophil trafficking.

SGPL1 S1PR1

5.83e-06349221173151
Pubmed

A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.

ETS1 ETS2

5.83e-0634928871649
Pubmed

The Ets1 transcription factor is widely expressed during murine embryo development and is associated with mesodermal cells involved in morphogenetic processes such as organ formation.

ETS1 ETS2

5.83e-0634927689222
Pubmed

Transactivation of the Moloney murine leukemia virus and T-cell receptor beta-chain enhancers by cbf and ets requires intact binding sites for both proteins.

ETS1 ETS2

5.83e-0634927609063
Pubmed

Transcription factors Ets1, Ets2, and Elf1 exhibit differential localization in human endometrium across the menstrual cycle and alternate isoforms in cultured endometrial cells.

ETS1 ETS2

5.83e-06349210377039
Pubmed

Regulation of the human interleukin-5 promoter by Ets transcription factors. Ets1 and Ets2, but not Elf-1, cooperate with GATA3 and HTLV-I Tax1.

ETS1 ETS2

5.83e-06349210212281
Pubmed

Sequence-specific DNA binding of the proto-oncoprotein ets-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus.

ETS1 ETS2

5.83e-0634922163347
Pubmed

MicroRNA 17-92 cluster mediates ETS1 and ETS2-dependent RAS-oncogenic transformation.

ETS1 ETS2

5.83e-06349224968297
Pubmed

Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2.

ETS1 ETS2

5.83e-06349228119415
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

TRPM6 CAPN13 TPTE KCTD10 EIF3C LYN YES1 EIF3CL

7.65e-0673049834857952
Pubmed

ETS2 overexpression ameliorates cartilage injury in osteoarthritis by the ETS2/miR-155/STAT1/DNMT1 feedback loop pathway.

ETS2 DNMT1

1.16e-05449237524226
Pubmed

IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.

ETS1 ETS2

1.16e-05449210815800
Pubmed

EAPII interacts with ETS1 and modulates its transcriptional function.

ETS1 ETS2

1.16e-05449212743594
Pubmed

A unique role for Fyn in CNS myelination.

LYN YES1

1.16e-05449211245687
Pubmed

Interaction between the Ret finger protein and the Int-6 gene product and co-localisation into nuclear bodies.

EIF3C EIF3CL

1.16e-05449210504338
Pubmed

Advancing precision medicine for prostate cancer through genomics.

ETS1 ETS2

1.16e-05449223589550
Pubmed

Regulation of transcription of the human presenilin-1 gene by ets transcription factors and the p53 protooncogene.

ETS1 ETS2

1.16e-05449210942770
Pubmed

Differential trafficking of Src, Lyn, Yes and Fyn is specified by the state of palmitoylation in the SH4 domain.

LYN YES1

1.16e-05449219258394
Pubmed

p21rasGAP association with Fyn, Lyn, and Yes in thrombin-activated platelets.

LYN YES1

1.16e-0544921544885
Pubmed

Transcriptional regulation of the apolipoprotein F (ApoF) gene by ETS and C/EBPα in hepatoma cells.

ETS1 ETS2

1.16e-05449225726912
Pubmed

p300/cAMP-responsive element-binding protein interactions with ets-1 and ets-2 in the transcriptional activation of the human stromelysin promoter.

ETS1 ETS2

1.16e-05449210358095
Pubmed

The SAM domain of human TEL2 can abrogate transcriptional output from TEL1 (ETV-6) and ETS1/ETS2.

ETS1 ETS2

1.16e-05449222615925
Pubmed

Non-canonical NF-κB signalling and ETS1/2 cooperatively drive C250T mutant TERT promoter activation.

ETS1 ETS2

1.16e-05449226389665
Pubmed

Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.

ETS1 ETS2

1.16e-05449210918595
Pubmed

Dnmt1N/+ reduces the net growth rate and multiplicity of intestinal adenomas in C57BL/6-multiple intestinal neoplasia (Min)/+ mice independently of p53 but demonstrates strong synergy with the modifier of Min 1(AKR) resistance allele.

PLA2G2A DNMT1

1.16e-05449210919675
Pubmed

Regulation of CSF-1 receptor expression.

ETS1 ETS2

1.16e-0544928981363
Pubmed

Ets-1 regulates plasma cell differentiation by interfering with the activity of the transcription factor Blimp-1.

ETS1 ETS2

1.16e-05449217977828
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

SETD2 ZNF644 TFIP11 EIF3C RFX1 NIPBL DNMT1 EIF3CL

1.17e-0577449815302935
Pubmed

Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases.

LYN YES1

1.94e-05549212846735
Pubmed

Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts.

SGPL1 S1PR1

1.94e-05549225333900
Pubmed

Ras/mitogen-activated protein kinase signaling activates Ets-1 and Ets-2 by CBP/p300 recruitment.

ETS1 ETS2

1.94e-05549215572696
Pubmed

c-Myb and members of the c-Ets family of transcription factors act as molecular switches to mediate opposite steroid regulation of the human glucocorticoid receptor 1A promoter.

ETS1 ETS2

1.94e-05549216263717
Pubmed

Lymphatic endothelial S1P promotes mitochondrial function and survival in naive T cells.

SGPL1 S1PR1

1.94e-05549228538737
Pubmed

The Ets transcription factors interact with each other and with the c-Fos/c-Jun complex via distinct protein domains in a DNA-dependent and -independent manner.

ETS1 ETS2

1.94e-0554929334186
Pubmed

Gene transcription of fgl2 in endothelial cells is controlled by Ets-1 and Oct-1 and requires the presence of both Sp1 and Sp3.

ETS1 FGL2

1.94e-05549212752447
Pubmed

Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis.

ETS1 ETS2

1.94e-05549219411629
Pubmed

Vav2 is required for cell spreading.

LYN YES1

1.94e-05549211448999
Pubmed

Factor VIIa/tissue factor-induced signaling via activation of Src-like kinases, phosphatidylinositol 3-kinase, and Rac.

LYN YES1

1.94e-05549210844001
Pubmed

Mutant p53 protects ETS2 from non-canonical COP1/DET1 dependent degradation.

ETS2 COP1

1.94e-05549226871468
Pubmed

Resequencing analysis of the human tyrosine kinase gene family in pancreatic cancer.

LYN YES1

1.94e-05549219893451
Pubmed

The mouse neurological mutant weaver maps within the region of chromosome 16 that is homologous to human chromosome 21.

ETS1 ETS2

2.91e-0564922575584
Pubmed

Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.

LYN YES1

2.91e-05649210861086
Pubmed

Tyrosyl phosphorylation of Shp2 is required for normal ERK activation in response to some, but not all, growth factors.

LYN YES1

2.91e-05649212923167
Pubmed

Kit signaling through PI 3-kinase and Src kinase pathways: an essential role for Rac1 and JNK activation in mast cell proliferation.

LYN YES1

2.91e-0564929799234
Pubmed

Opposing functions of the ETS factor family define Shh spatial expression in limb buds and underlie polydactyly.

ETS1 ETS2

2.91e-05649222340503
Pubmed

Two additional protein-tyrosine kinases expressed in human lung: fourth member of the fibroblast growth factor receptor family and an intracellular protein-tyrosine kinase.

LYN YES1

2.91e-0564921720539
Pubmed

Steel factor stimulates the tyrosine phosphorylation of the proto-oncogene product, p95vav, in human hemopoietic cells.

LYN YES1

2.91e-0564921381360
Pubmed

Systematic analysis of human protein complexes identifies chromosome segregation proteins.

FAM120A LMNB1 ZNF644 KCTD10 TFIP11 EIF3C YES1 NIPBL EIF3CL

2.96e-05115549920360068
Pubmed

Regulation of a transient receptor potential (TRP) channel by tyrosine phosphorylation. SRC family kinase-dependent tyrosine phosphorylation of TRPV4 on TYR-253 mediates its response to hypotonic stress.

LYN YES1

4.07e-05749212538589
Pubmed

Associations and interactions between Ets-1 and Ets-2 and coregulatory proteins, SRC-1, AIB1, and NCoR in breast cancer.

ETS1 ETS2

4.07e-05749215788656
Pubmed

QM, a putative tumor suppressor, regulates proto-oncogene c-yes.

LYN YES1

4.07e-05749212138090
Pubmed

Membrane glycoprotein IV (CD36) is physically associated with the Fyn, Lyn, and Yes protein-tyrosine kinases in human platelets.

LYN YES1

4.07e-0574921715582
Pubmed

Collagen, convulxin, and thrombin stimulate aggregation-independent tyrosine phosphorylation of CD31 in platelets. Evidence for the involvement of Src family kinases.

LYN YES1

4.07e-05749210858437
Pubmed

Proline-rich sequences that bind to Src homology 3 domains with individual specificities.

LYN YES1

4.07e-0574927536925
Pubmed

Charcot-Marie-Tooth Hereditary Neuropathy Overview

SGPL1 CNTNAP1 DNMT1

4.35e-054849320301532
Pubmed

Polymorphisms in innate immunity genes and patients response to dendritic cell-based HIV immuno-treatment.

TRAF4 PLA2G2A LYN YES1

4.76e-0514149420056178
Pubmed

The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation.

LYN YES1

5.42e-05849221309750
Pubmed

Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis.

LYN YES1

5.42e-05849231101761
Pubmed

The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association.

LYN YES1

5.42e-05849220605918
Pubmed

Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.

LYN YES1

5.42e-05849215190072
Pubmed

Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis.

LYN YES1

5.42e-05849216921024
Pubmed

Erg proteins, transcription factors of the Ets family, form homo, heterodimers and ternary complexes via two distinct domains.

ETS1 ETS2

5.42e-0584929681824
Pubmed

Identification of a new adapter protein that may link the common beta subunit of the receptor for granulocyte/macrophage colony-stimulating factor, interleukin (IL)-3, and IL-5 to phosphatidylinositol 3-kinase.

LYN YES1

5.42e-0584927499252
Pubmed

Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.

FAM120A LMNB1 SGPL1 KCTD10 UGGT1 ASCC3 LYN DNMT1 EIF3CL

5.70e-05125749936526897
Pubmed

The pleiotropic mouse phenotype extra-toes spotting is caused by translation initiation factor Eif3c mutations and is associated with disrupted sonic hedgehog signaling.

EIF3C EIF3CL

6.96e-05949221292980
Pubmed

Dynamin genes Dnm1 and Dnm2 are located on proximal mouse chromosomes 2 and 9, respectively.

ETS1 NEB

6.96e-0594929143510
Pubmed

TNF receptor-associated factor 4 (TRAF4) is a novel binding partner of glycoprotein Ib and glycoprotein VI in human platelets.

TRAF4 LYN

6.96e-05949220946164
Pubmed

PSD-95 promotes Fyn-mediated tyrosine phosphorylation of the N-methyl-D-aspartate receptor subunit NR2A.

LYN YES1

6.96e-0594929892651
Pubmed

Lyn, a Src family kinase, regulates activation of epidermal growth factor receptors in lung adenocarcinoma cells.

LYN YES1

6.96e-05949223866081
Pubmed

The m subunit of murine translation initiation factor eIF3 maintains the integrity of the eIF3 complex and is required for embryonic development, homeostasis, and organ size control.

EIF3C EIF3CL

6.96e-05949224003236
InteractionGP6 interactions

TRAF4 LYN YES1

7.40e-0616493int:GP6
CoexpressionNAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_DN

S100A8 VPS11 SGPL1 LYN YES1 NIPBL GNS

8.90e-06399497M40939
CoexpressionTRAVAGLINI_LUNG_CLASSICAL_MONOCYTE_CELL

S100A8 FAM120A ETS2 LYN GNS FGL2

1.09e-05270496M41699
CoexpressionGSE7219_WT_VS_NIK_NFKB2_KO_DC_UP

TRAF4 LMNB1 ETS2 TFIP11 FGL2

2.46e-05185495M377
CoexpressionGSE24634_TREG_VS_TCONV_POST_DAY5_IL4_CONVERSION_DN

S100A8 VPS11 VNN2 SGPL1 LYN

3.40e-05198495M4603
CoexpressionGSE17721_0.5H_VS_4H_CPG_BMDC_DN

VNN2 KCTD10 ETS2 COP1 APBB1IP

3.57e-05200495M4125
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 KY LMNB1 VNN2 ETS2 LYN

4.14e-08177496fd739ae4a574b72dc26a2a9ff4ef988454298ead
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 EIF3C LYN GNS EIF3CL FGL2

6.50e-08191496c9f3bdb5c0a90268cab24a0fe4c3a8290fcedeb8
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_1|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

S100A8 EIF3C LYN GNS EIF3CL FGL2

6.70e-08192496b86476037ddf8904c1d8a6b3763af7242c031cf3
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-08198496cf0fda1a24449cfd8ed56ffc7841d8accb187949
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-081984967e1f08dae11a7cc7949a5622d82c7e6660d06dea
ToppCellPBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-08198496a8338da2477ccf8e3d924de8dbe1056b98111532
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-0819849670e62d815b2a0aa5327ff94d6f4d503176e007b9
ToppCellCOVID-19_Severe-Myeloid-Classical_Monocyte|COVID-19_Severe / Disease group, lineage and cell class

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-08198496dfe92577c7d1e63315c7564d5d99362c6e7d4d46
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-0819849651c220507bb05aa6338fec494b8ecf4902437708
ToppCellPBMC-Severe-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.04e-08198496603846129560d5d6e6df27d6168f67f592e5e6e2
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.29e-081994969314eb9a89407738626a0384884454b5f9031ee7
ToppCellPBMC-Mild-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

S100A8 VNN2 ETS2 LYN GNS FGL2

8.29e-08199496dbf0bf09896c46155ae6fbd6307f097799e7e34e
ToppCellsevere-HLA-DR-_S100A+_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

S100A8 VNN2 ETS2 LYN GNS FGL2

8.54e-08200496a5eb50cbf3e94f0b3aa0fbef888989a11cffea37
ToppCellCOVID-19-COVID-19_Severe-Myeloid-CD14+_Monocyte|COVID-19_Severe / Disease, condition lineage and cell class

S100A8 VNN2 ETS2 LYN GNS FGL2

8.54e-082004966abee30708572519045e9456dac2017b5308817a
ToppCellCOVID-19-COVID-19_Severe-Myeloid|COVID-19_Severe / Disease, condition lineage and cell class

S100A8 VNN2 ETS2 LYN GNS FGL2

8.54e-082004961315bc0582b19c2fed91c740a1a7e9285c700df1
ToppCelldroplet-Lung-LUNG-1m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS2 LCT FGL2

8.44e-0715849530cceb73cf5e24b692da84d33342fd3b1ad5efe5
ToppCelldroplet-Lung-LUNG-1m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS2 LCT FGL2

8.44e-0715849547793463640f98ee5f680a1ee5786b453355fd57
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Neutrophil|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

S100A8 REG4 VNN2 LYN APBB1IP

1.08e-061664956a65dff1333f39ec8c584e6df04b8c1e7f1c8946
ToppCellLPS-IL1RA+antiTNF-Myeloid-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

S100A8 LMNB1 VNN2 LYN APBB1IP

1.69e-06182495243c783675df495ea4112dbf710712c44ea6b4f1
ToppCellLPS-IL1RA+antiTNF-Myeloid-Neutrophils-Neutrophils|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

S100A8 LMNB1 VNN2 LYN APBB1IP

1.69e-0618249518790a394dc32b3cef99cdbf826392c520e38b4a
ToppCellwk_08-11-Hematologic-Myeloid-Neutrophil|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

S100A8 VNN2 LYN APBB1IP FGL2

1.83e-06185495655fb705d7a029844ecb4f6a53e948e37ee81006
ToppCellLPS-IL1RA+antiTNF-Myeloid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

S100A8 VNN2 LYN APBB1IP FGL2

1.93e-061874954e0bbef6ba0d1b3e1f8d900d4a9dbd41f09a7bc5
ToppCellsaliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 LMNB1 VNN2 ETS2 LYN

2.09e-06190495212f0d9defcc3174e225cc3d90e7814e238794b6
ToppCellNS-moderate-d_16-33-Myeloid-Neutrophil|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

S100A8 LMNB1 VNN2 ETS2 LYN

2.20e-06192495545c3990cbe3c04bfd95a0ab7499d2c4af509be1
ToppCellmoderate-Myeloid-Neutrophil|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

S100A8 LMNB1 VNN2 ETS2 LYN

2.20e-061924958105408400dac5dcb0ce62b558433257559c9f09
ToppCellPCW_13-14-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_immature_monocyte2_(4)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

S100A8 VNN2 LYN APBB1IP FGL2

2.20e-061924956ac7ba0ef7d1b4f85dc12fa3f0ebaddc57f214a5
ToppCellMonocytes-Inflammatory_CD16+_macrophages|World / Immune cells in Kidney/Urine in Lupus Nephritis

S100A8 ETS2 LYN GNS FGL2

2.20e-061924954be5c2c946337cd3e710137726358adca563f146
ToppCellfacs-Thymus-nan-3m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS1 ETS2 NIPBL

2.31e-06194495f1661f9f2439fca5c1012c693b0744c4e3b90a9b
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 LMNB1 VNN2 ETS2 LYN

2.31e-06194495b04cbd240c59755ef7bdeb17fee3028caef6dedb
ToppCellfacs-Thymus-nan|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS1 ETS2 NIPBL

2.31e-06194495cda1b197efb199330ea7ab25a7cee22cae22589d
ToppCellfacs-Thymus-nan-3m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS1 ETS2 NIPBL

2.31e-0619449566c056232ac216780acf4cc8ea325bd8ed1909c9
ToppCellsaliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 LMNB1 VNN2 ETS2 LYN

2.31e-06194495744fd4580942183a1058717d0c3ac86483e366ed
ToppCelldroplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

KY FAM120A UGGT1 ASCC3 GNS

2.37e-061954957796ea9247f4c63762f0de8490fed08b9717fa23
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Monocytic-Classical_Monocyte-Mono_c1-CD14-CCL3|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 ETS2 LYN FGL2

2.43e-061964951d170422a9eb5e477ce837f9da1c7db95ee5da1c
ToppCellCOVID-19-Myeloid-Monocytes|COVID-19 / group, cell type (main and fine annotations)

S100A8 ETS2 LYN APBB1IP FGL2

2.43e-0619649504d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCellBL-critical-LOC-Myeloid-Neutrophil|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

S100A8 LMNB1 VNN2 ETS2 LYN

2.43e-06196495f64d7fed31e418c55fe946744d78c3cbecec9bbf
ToppCellBL-critical-LOC-Myeloid|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)

S100A8 VNN2 ETS2 LYN FGL2

2.49e-06197495932a7fae4979b561688e6222505df0f4e510ab11
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

S100A8 ETS2 LYN GNS FGL2

2.49e-06197495a1d42d0177630e08f36a96a6272f796244c1a319
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 ETS2 LYN GNS FGL2

2.49e-06197495bb0d814d88a14199eb8ab2b3bd67511b19e3ab5d
ToppCellSmart-start-Cell-Wel_seq-Non-neoplastic-Myeloid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

S100A8 ETS2 LYN APBB1IP FGL2

2.56e-0619849500a54af5267bfe0eeab6720bf890dc4b6b803bfd
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

S100A8 ETS2 LYN GNS FGL2

2.56e-06198495525adc91fd8f2ad957b1879a5bf3950baa7d5ef8
ToppCellPBMC-Severe-Myeloid-Classical_Monocyte|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)

S100A8 ETS2 LYN GNS FGL2

2.56e-061984950128d00e6c3f99a026329dd169c0ea5e0e24c59c
ToppCellmoderate-Myeloid-Neutrophil|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls

S100A8 LMNB1 VNN2 ETS2 LYN

2.56e-06198495a6306dac34af5783f3a734ef1eaa7a0c03267b4f
ToppCellPBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)

S100A8 ETS2 LYN GNS FGL2

2.62e-0619949502256d86541be6851634283047fdc05fdf095114
ToppCell3'_v3-Lung-Myeloid_Monocytic|Lung / Manually curated celltypes from each tissue

S100A8 VNN2 ETS2 LYN FGL2

2.62e-061994953e14f9a62d6414add8d5f681be184b4625001838
ToppCellPBMC-Mild-Myeloid|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 ETS2 LYN GNS FGL2

2.62e-0619949527667838e065370d4536eaaf5b42ad322a714b96
ToppCellCOVID-19_Mild-Myeloid|COVID-19_Mild / Disease group, lineage and cell class

S100A8 ETS2 LYN GNS FGL2

2.62e-06199495d0c230c3699955a80630b63ed18c770444c5dfe5
ToppCellCOVID-19_Severe-Myeloid|COVID-19_Severe / Disease group, lineage and cell class

S100A8 ETS2 LYN GNS FGL2

2.62e-06199495babbf3220cc811a1794032e06c6cec4dfc7bff2f
ToppCellInt-URO|World / Disease, Lineage and Cell Type

S100A8 VNN2 LYN GNS FGL2

2.62e-06199495792a8717c048854952ca26cdc58d325f2ece6c1a
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

S100A8 ETS2 LYN APBB1IP FGL2

2.62e-061994957504835a0849a7074d19d6cf7e3ec61586c85fdf
ToppCellnormal_Pleural_Fluid-Myeloid_cells-Pleural_Mac|normal_Pleural_Fluid / Location, Cell class and cell subclass

S100A8 ETS2 LYN GNS FGL2

2.69e-062004951798eb621dccb4ccae18d9b3df558a6428d30542
ToppCellsevere-Classical_Monocyte|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

S100A8 VNN2 LYN GNS FGL2

2.69e-06200495ce03be0ccfc22eb923302a2ad73b39752e888270
ToppCellInfluenza-Influenza_Severe-Myeloid|Influenza_Severe / Disease, condition lineage and cell class

S100A8 ETS2 LYN GNS FGL2

2.69e-062004952bf931ec2c6165698ba600b151fd30d8dd921d95
ToppCell10x_3'_v3-spleen_(10x_3'_v3)-myeloid|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

S100A8 VNN2 ETS2 LYN FGL2

2.69e-062004956da31ce0a70ad5621444d731c082c0db572c20c5
ToppCellCOVID_vent-Myeloid-Monocytic|COVID_vent / Disease condition, Lineage, Cell class and subclass

S100A8 VNN2 LYN GNS FGL2

2.69e-06200495b0a5bee87700ce38f26f95a6f491da7e27cade51
ToppCellCOVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

S100A8 ETS2 LYN GNS FGL2

2.69e-06200495a40768e8e58c86b8e20bc188b9274ebe412fc765
ToppCellsevere-Classical_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class

S100A8 VNN2 ETS2 LYN FGL2

2.69e-06200495f46689940fdea500ce2457eec412dd2c46705819
ToppCellCOVID-19-COVID-19_Mild-Myeloid|COVID-19_Mild / Disease, condition lineage and cell class

S100A8 ETS2 LYN GNS FGL2

2.69e-06200495247040492b3c327f4144fc94cf210dc04eecc7b0
ToppCellCOVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

S100A8 ETS2 LYN GNS FGL2

2.69e-062004954243a9d32f3a11141284d0d944cb81194b532876
ToppCell390C-Myeloid-Monocyte-CD14+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells)

S100A8 VNN2 FGL2

7.09e-06344933ff1ad679da59252f0e3caec27f25d3f30984d7f
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 APBB1IP FGL2

2.74e-05158494d43b335e6aa12d84a75b988fbd6127ff1f4af25c
ToppCellfacs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 APBB1IP FGL2

2.74e-05158494ab12b29ce51ca2fcac469cc932391217d97145f9
ToppCelldroplet-Lung-1m-Hematologic-myeloid-neutrophil-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100A8 LMNB1 ETS2 FGL2

2.81e-05159494be54b910ccb73e37eb81945bbad9a89d2bcec34b
ToppCelldroplet-Lung-1m-Hematologic-myeloid-neutrophil|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100A8 LMNB1 ETS2 FGL2

2.81e-05159494178678173b005cb8225472306657f0d8289b133b
ToppCellfacs-Lung-EPCAM-3m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 REG4 LMNB1 FGL2

2.88e-05160494b73f07a0088936fbc3656a05710a67f38b4ae551
ToppCellfacs-MAT-Fat-18m-Myeloid-myeloid_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS2 LYN

2.88e-05160494bd5fa7959bfe81011b8d798535b73ea1eee008b3
ToppCellfacs-Lung-EPCAM-3m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 REG4 LMNB1 FGL2

2.88e-05160494b88876a58fea2066468e74dcc439c8561130a910
ToppCellfacs-Lung-18m-Hematologic-myeloid-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100A8 LMNB1 APBB1IP FGL2

3.02e-05162494ad974426039f4952c59d27167eac24dc6ce63f5e
ToppCellfacs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

S100A8 LMNB1 APBB1IP FGL2

3.02e-051624944e7e565091bce227d794a36af2e5dfc4a791efad
ToppCellfacs-BAT-Fat-18m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS2 FGL2

3.57e-05169494d3e6c75e5eda133fb6535cfe6c6a1026641f26ac
ToppCell390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)

S100A8 PDE6A PLA2G2A FGL2

3.57e-05169494d2def7229fe9d6b0c70cfed349ede491c8c137a0
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

S100A8 REG4 VNN2 LYN

3.57e-051694942e15a9317da4017757d184f7cc91bd66b072ac51
ToppCelldroplet-Lung-nan-18m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 ETS2 S1PR1 FGL2

3.57e-05169494f0f97ca415aef619b8b4b1399ad5e0823267516e
ToppCellfacs-BAT-Fat-3m-Myeloid-granulocyte|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

S100A8 LMNB1 ETS2 FGL2

3.65e-051704948fd0a55266066a51266ab616c38c883e2680bcf4
ToppCelldroplet-Lung-18m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

ETS1 ETS2 S1PR1 FGL2

3.65e-05170494683c4aa74689791944b6f3998dba51a4456fbc49
ToppCelldroplet-Pancreas-Endocrine-21m-Hematologic-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 LYN S1PR1 APBB1IP

3.65e-051704946086d658a52a1961a1e293cbc3703ae8d309cd11
ToppCellCTRL-Myeloid-Monocyte|Myeloid / Disease state, Lineage and Cell class

S100A8 LMNB1 ETS2 FGL2

3.73e-05171494bfa01571516a0b24476ae06cb07f56c5579dbd70
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 LMNB1 VNN2 UGGT1

3.73e-051714942b7c5a557c4bc5c573211c4d618bdd6766a24916
ToppCellsaliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 LMNB1 VNN2 UGGT1

3.73e-05171494dcb15bc54aeea06ef8f07f1134f3ff1e21ac0e4f
ToppCellCTRL-Myeloid-Neutrophil|CTRL / Disease state, Lineage and Cell class

TRPM6 S100A8 VNN2 LYN

3.82e-05172494ef3a6fe3b7300959f9f71130200c7fb8741c42b0
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Neutrophil|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

S100A8 VNN2 LYN APBB1IP

3.91e-05173494dfa56753319c92ae5b337793c4d6d5f70afce546
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c4-RSAD2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 ETS2 LYN

4.37e-0517849494a86f5232fffa6a92a30ea21fb44eec33b4d6c8
ToppCelldroplet-Tongue-nan-24m-Myeloid-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRPM6 ETS1 APBB1IP FGL2

4.46e-051794941b079d80f789473701c781f3431ad306e9766797
ToppCellEpithelial-basal_cell|World / Lineage, Cell type, age group and donor

TRPM6 CAPN13 ETS2 GRHL2

4.46e-05179494d9be6647ec7b22747dc00dce4ea307b6af412dfa
ToppCelldroplet-Kidney-nan-3m-Hematologic-nan|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 S1PR1 APBB1IP FGL2

4.66e-0518149458d7e76dfaa818aeaef7f129c4472bf5b6563218
ToppCelldroplet-Kidney-nan-3m-Hematologic|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 S1PR1 APBB1IP FGL2

4.66e-051814945d76e99bf2b5b337041efd3cd33bebbb0637b64e
ToppCelldroplet-Kidney-nan-3m-Hematologic-leukocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 S1PR1 APBB1IP FGL2

4.66e-05181494970fc90e27236ee30190f1a02f418a378919c60b
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 ETS2 LYN

4.76e-05182494f9c013075477e77a8373c73301a51e7e3f35369c
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 ETS2 LYN

4.86e-05183494340621a8e720bd98da335f90598096833681834c
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

S100A8 ETS2 LYN FGL2

4.86e-051834944763df29c888d47c22076803b054f06b4cc29368
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Myeloid-Granulocytic-Neutrophil|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 ETS2 LYN

4.86e-0518349475da8c05b6d636f434c5684e0166fed0de3547b4
ToppCellPBMC-Control-Myeloid-Classical_Monocyte-Classical_Monocyte-cMono_3|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

S100A8 ETS2 LYN FGL2

4.86e-05183494fcb0f755382d88fb207fc2322cd224c09c6e2ea6
ToppCellSmart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TRPM6 S100A8 VNN2 PLA2G2A

4.97e-051844947ecdf2645e9378cf2f5ce4557f2cf100e6f184ba
ToppCelldroplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARMC9 CLSTN1 ZRANB3 FGL2

5.07e-05185494bb5a4cf93534b9bcd0923f314c389d571e91e7f8
ToppCelldroplet-Heart-nan-24m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 ETS2 LYN S1PR1

5.07e-0518549411a44006950f6ccade86a85d5f06696d2036ffde
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c3-CST7|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 LYN FGL2

5.07e-0518549497f8a644f51c02a5f8a74d8c923ad637a15ed06d
ToppCelldroplet-Heart-nan-24m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ETS1 ETS2 LYN S1PR1

5.18e-051864948b316bfed39b91c15d5ae28d9261eb057f113796
ToppCellPBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)

S100A8 VNN2 LYN FGL2

5.18e-0518649405c40bac5c0ade8b67b7c2112739466e02dbf22b
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

S100A8 PDE6A ETS2 FGL2

5.18e-0518649423b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellTCGA-Uvea-Primary_Tumor-Uveal_Melanoma-Epithelioid_Cell|TCGA-Uvea / Sample_Type by Project: Shred V9

SGPL1 ARMC9 LYN DNMT1

5.18e-05186494e8580a2093eb7e50aad55ec7fada850d2fed8ae1
Diseasemuscle measurement

REG4 NEB

1.49e-054472EFO_0004515
Diseasekidney disease (implicated_via_orthology)

LCT LYN YES1

3.87e-0541473DOID:557 (implicated_via_orthology)
Diseaseirritable bowel syndrome

FAM120A COP1 ASCC3 CLSTN1

5.71e-05131474EFO_0000555
Diseaseasparaginase-induced acute pancreatitis

ADAMTS18 NEB

8.88e-059472EFO_1001507
DiseaseCongenital myopathy (disorder)

KY NEB

1.62e-0412472C0270960
Diseasemonocyte count

S100A8 SETD2 KCTD10 ETS1 ARMC9 LCT LYN CLSTN1 DNMT1

2.04e-041320479EFO_0005091
Diseaselymphocyte count

SETD2 SGPL1 ZNF644 ETS1 CLSTN1 GRHL2 S1PR1 APBB1IP DNMT1

4.39e-041464479EFO_0004587
Diseasegranulocyte count

REG4 ETS1 LYN DNMT1

7.15e-04254474EFO_0007987
Diseasemonocyte percentage of leukocytes

SETD2 ETS1 ARMC9 LYN S1PR1 APBB1IP

1.02e-03731476EFO_0007989
Diseasecolorectal cancer (implicated_via_orthology)

LYN YES1

1.05e-0330472DOID:9256 (implicated_via_orthology)
Diseaseintestinal cancer (implicated_via_orthology)

LYN YES1

1.19e-0332472DOID:10155 (implicated_via_orthology)
DiseaseEczema, Infantile

S100A8 VNN2

1.51e-0336472C0086196
DiseaseDermatitis, Atopic

S100A8 VNN2

1.51e-0336472C0011615

Protein segments in the cluster

PeptideGeneStartEntry
NNSLYLYYKGLSKTL

COP1

661

Q8NHY2
VKLLYNRSNNKYSYT

KCTD10

161

Q9H3F6
LVLFYLQNHRYKGSY

CNTNAP1

1301

P78357
EHYRKYSDYIKGSNL

DNMT1

971

P26358
IAKYGKTLYDNYQRA

APBB1IP

416

Q7Z5R6
KAYAKLLGSYSDLHY

CAPN13

171

Q6MZZ7
NYGKEHQYKLTVTAY

CLSTN1

226

O94985
YKGLYLNQHKANEYY

ADAMTS18

751

Q8TE60
NKKYQYYSNKHCRGS

PLA2G2A

126

P14555
NHNFYSYILKYKVNA

KY

646

Q8NBH2
TYLKRYNKIQADYHN

ARMC9

226

Q7Z3E5
SYKYTSRYVLKAGQT

LMNB1

481

P20700
YYDKNIIHKTAGKRY

ETS1

396

P14921
KQYYNLHYRAKLISD

PDE6A

21

P16499
LRYYYDKNIIHKTSG

ETS2

421

P15036
NRYYGAISKLKSQHQ

NIPBL

2111

Q6KC79
YHKTYINEALKAYRL

LCT

1291

P09848
YYFSAHALKLSRNGK

FAM120A

196

Q9NZB2
YYKFDYKAHQRQLTP

EIF3C

511

Q99613
TYYKFDYKAHQRQLT

EIF3CL

511

B5ME19
YSYNNRSNKPIHRAY

GRHL2

396

Q6ISB3
YYNYTLSINGKARKH

GNS

181

P15586
KHYKIRSLDNGGYYI

LYN

181

P07948
SANLNGKYYHQKYRG

FGL2

386

Q14314
QSKDYYAYRLGHILN

CST9L

61

Q9H4G1
NYDIIVRHYNYTGKL

S1PR1

21

P21453
RQGSYHLATKKYTQA

IFT140

1201

Q96RY7
YHKSNCYGYFRKLRN

REG4

36

Q9BYZ8
FVKYYHAKNGRAYVE

RUNDC1

476

Q96C34
YHKYSLIKGNFHAVY

S100A8

16

P05109
NSKYHYYGLRIKASS

RFX1

501

P22670
HLKQIAYYKRTGEYH

GIN1

11

Q9NXP7
IYVYTKLQNTEYRKH

RNASEL

701

Q05823
SSLVLYSDKKYRNYQ

SGPL1

361

O95470
LGRTASHYYIKYNTI

ASCC3

981

Q8N3C0
GRIASYYYLKHQTVK

ASCC3

1816

Q8N3C0
VYNTEGKLVARYHKY

VNN2

166

O95498
KRYVAYFAQVKHLYN

TPTE

391

P56180
YHHSKIRNRGYNLIY

TMEM192

116

Q8IY95
KVLRQAGYYSHALYL

VPS11

491

Q9H270
ALYNNLYRKYKHQRH

TRPM6

536

Q9BX84
AFYTHKYGYKLQVSA

TRAF4

336

Q9BUZ4
ARVKEYARNKNIHYY

SETD2

1591

Q9BYW2
NAKANSHYLYRHKYE

ZNF644

731

Q9H582
TAIRHNPQKAQYYLY

TTC16

431

Q8NEE8
QKVYYSYSQISHKHN

TFIP11

276

Q9UBB9
SKSNAGKINYVFRHY

UGGT1

216

Q9NYU2
YAKRYCNAHIRYFGK

ZRANB3

216

Q5FWF4
HYKIRKLDNGGYYIT

YES1

211

P07947
YKYKQGYRKQLGHHV

NEB

2306

P20929